Recent advances in amebiasis.
Advancements in our understanding of amebiasis have been rapid over the decade that I have followed this field. What was identified morphologically for years as Entamoeba histolytica has been redescribed with modern techniques as a complex of two species, the commensal parasite E. dispar and the pathogenic parasite E. histolytica that is the cause of colitis and liver abscess. Antigen detection tests are now available for the rapid detection in stool of the pathogenic species E. histolytica. New understandings of the importance of luminal as well as tissue-active antimebic medications in the treatment of invasive disease have been reached. The groundwork is being laid for an understanding of the protective immune responses to infection, and at the lab bench DNA transfection of the parasite has opened studies of pathogenesis to genetic analysis. While necessarily an incomplete sketch of the field, I have attempted here to highlight some recent and important developments of interest to clinicians and microbiologists.
Petri
W A
WA
Department of Internal Medicine, University of Virginia, Charlottesville 22908, USA.
D000818:Animals; D000953:Antigens, Protozoan / Q000032:analysis; D001483:Base Sequence; D016054:DNA, Protozoan / Q000032:analysis; D004747:Entamoeba / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification / Q000502:physiology; D004749:Entamoebiasis / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D005243:Feces / Q000469:parasitology; D006801:Humans; D008969:Molecular Sequence Data
D000953:Antigens, Protozoan; D016054:DNA, Protozoan